ENCORE DERMATOLOGY, INC. – Trademark Portfolio

Entity Type: 03

ENCORE DERMATOLOGY, INC. holds 24 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 20 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include IMPOYZ, TETRIX, SERNIVO, PROMISEB, and BENZEFOAM. The owner is based in MALVERN, PA.

5 GREAT VALLEY PARKWAY

MALVERN, PA 19355

24 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ENCORE DERMATOLOGY, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (20 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (4 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does ENCORE DERMATOLOGY, INC. have?

ENCORE DERMATOLOGY, INC. has 24 U.S. trademarks filed with the USPTO. Of these, 9 registered, 11 abandoned, 4 cancelled.

What trademark classes does ENCORE DERMATOLOGY, INC. file in?

ENCORE DERMATOLOGY, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ENCORE DERMATOLOGY, INC.'s most well-known trademarks?

ENCORE DERMATOLOGY, INC.'s registered trademark portfolio includes well-known marks such as IMPOYZ, TETRIX, SERNIVO, PROMISEB, and BENZEFOAM. These are among 9 currently registered trademarks in the portfolio.

What is ENCORE DERMATOLOGY, INC.'s trademark registration success rate?

ENCORE DERMATOLOGY, INC. has a 38% trademark registration rate, with 9 out of 24 resolved applications resulting in successful registration. Currently, 0 applications are pending review.